Olivier Fitoussi
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 11, 2025
Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma).
Journal: JMIR cancer
Published: August 31, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration.
Journal: Leukemia
Published: April 03, 2024
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 18, 2023
Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy.
Journal: Urologia internationalis
Published: August 03, 2022
Treatment emergent peripheral neuropathy in the CASSIOPEIA trial.
Journal: Haematologica
Published: January 18, 2022
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.
Journal: Leukemia
Published: May 18, 2021
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.
Journal: BMC public health
Published: October 06, 2020
Last Updated: 09/26/2026